• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
1
1
1

COUNTRY

1

CATEGORIES

  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
2
2
10

PUBLISHED

0
0
1
10

PRODUCT TYPE

8
2

Search "Prometheus Laboratories, Inc.-Therapeutic Competitors Report" returned 10 results.

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready?...

November 2009
FROM

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)

In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests...

March 2012
FROM

Worldwide Point of Care Diagnostic Test Markets

Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable,...

December 2010
FROM

The Worldwide Market for Cancer Diagnostics, 4th Edition

Since Kalorama Information last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of...

April 2010
FROM

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent...

January 2013
FROM

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro...

July 2012
FROM

Neurocrine Biosciences, Inc. (NBIX) - Financial and Strategic SWOT Analysis Review

Neurocrine Biosciences, Inc. (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2015
FROM

Growth Factors (Blood and Tissue) - Global Strategic Business Report

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons,...

June 2014
FROM

United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to the USA In vitro...

September 2009
FROM

Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis

Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis Summary Amorfix Life Sciences Ltd. (Amorfix) is a theranostics company engaged in developing therapeutic products and diagnostic devices...

August 2012
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.